This supports that PPPE patients have an increased risk of cardiovascular disease later in life and is reinforced by the elevated levels of IL17A and sCD40L in the circulation of PPPE patients, both of which have been linked to myocardial infarctions, stroke, and cardiovascular deaths (53–57). This evidence concerns the gene CD40LG and myocardial infarction.